SHL Telemedicine - Stock

SHL Telemedicine P/E 2024

SHL Telemedicine P/E

-26.59

SHL Telemedicine Dividend yield

17.93 %

Ticker

SHLTN.SW

ISIN

IL0010855885

WKN

589969

As of Jun 11, 2024, SHL Telemedicine's P/E ratio was -26.59, a 668.5% change from the -3.46 P/E ratio recorded in the previous year.

The SHL Telemedicine P/E history

SHL Telemedicine Aktienanalyse

What does SHL Telemedicine do?

SHL Telemedicine Ltd is a leading company in the field of telemedicine solutions and was founded in Israel in 1987. The company develops, produces, and distributes medical equipment and software applications to offer remote monitoring services for various industries. The company started as a pioneer in the telemedicine industry, manufacturing devices for remote monitoring of high blood pressure and diabetes. Today, the company offers a wide range of telemedicine devices and solutions that allow patients and medical professionals to maintain control over their health and medical data. SHL Telemedicine operates on a global level and has expanded its presence in various advanced countries, including Europe, North America, and the Asia-Pacific region. The company has also had strategic partnerships with various international organizations and governments to spread its telemedicine solutions worldwide. Business Model: The company operates under a business-to-business model and provides a range of cost-effective and high-quality telemedicine solutions for various industries, including life sciences, health technology, financial services, government organizations, and insurance. SHL Telemedicine offers its customers products and services related to remote monitoring, tele-diagnosis, teleconsultation, and patient management. The company's solutions are versatile and aim to improve the quality of healthcare and reduce costs. Products and Services: The company offers a wide range of products and services aimed at improving healthcare and providing medical professionals, patients, and decision-makers with improved control over their health. Some of the company's most well-known products and services include: 1. CardioSTAT: A solution for remote monitoring of heart patients 2. DiabetesSTAT: A device for remote monitoring of diabetes patients 3. GraB: A device for monitoring and treating sleep disorders 4. Carenet: A platform for tele-diagnosis and teleconsultation 5. SHL Connect: A platform that allows patients to track their health data online 6. eXzellenZ: A platform that enables medical professionals and doctors to provide remote monitoring services SHL Telemedicine is committed to offering a comprehensive and flexible range of telemedicine products and services to improve healthcare worldwide. The company aims to enhance patients' quality of life, increase the efficiency of medical care, and promote cost savings in the healthcare industry. SHL Telemedicine ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering SHL Telemedicine's P/E Ratio

The Price to Earnings (P/E) Ratio of SHL Telemedicine is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing SHL Telemedicine's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of SHL Telemedicine is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in SHL Telemedicine’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about SHL Telemedicine Stock

What is the price-to-earnings ratio of SHL Telemedicine?

The price-earnings ratio of SHL Telemedicine is currently -26.59.

How has the price-earnings ratio of SHL Telemedicine changed compared to last year?

The price-to-earnings ratio of SHL Telemedicine has increased by 668.5% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of SHL Telemedicine high compared to other companies?

Yes, the price-to-earnings ratio of SHL Telemedicine is high compared to other companies.

How does an increase in the price-earnings ratio of SHL Telemedicine affect the company?

An increase in the price-earnings ratio of SHL Telemedicine would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of SHL Telemedicine affect the company?

A decrease in the price-earnings ratio of SHL Telemedicine would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of SHL Telemedicine?

Some factors that influence the price-earnings ratio of SHL Telemedicine are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does SHL Telemedicine pay?

Over the past 12 months, SHL Telemedicine paid a dividend of 1 USD . This corresponds to a dividend yield of about 17.93 %. For the coming 12 months, SHL Telemedicine is expected to pay a dividend of 0 USD.

What is the dividend yield of SHL Telemedicine?

The current dividend yield of SHL Telemedicine is 17.93 %.

When does SHL Telemedicine pay dividends?

SHL Telemedicine pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of SHL Telemedicine?

SHL Telemedicine paid dividends every year for the past 0 years.

What is the dividend of SHL Telemedicine?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is SHL Telemedicine located?

SHL Telemedicine is assigned to the 'Health' sector.

Wann musste ich die Aktien von SHL Telemedicine kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of SHL Telemedicine from 4/16/2019 amounting to 1 USD, you needed to have the stock in your portfolio before the ex-date on 4/10/2019.

When did SHL Telemedicine pay the last dividend?

The last dividend was paid out on 4/16/2019.

What was the dividend of SHL Telemedicine in the year 2023?

In the year 2023, SHL Telemedicine distributed 0 USD as dividends.

In which currency does SHL Telemedicine pay out the dividend?

The dividends of SHL Telemedicine are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von SHL Telemedicine

Our stock analysis for SHL Telemedicine Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SHL Telemedicine Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.